A chemical screen identifies Trifluoperazine (cas 117-89-5) as an inhibitor of glioblastoma growth
-
Add time:08/28/2019 Source:sciencedirect.com
Glioblastoma (GBM) is regarded as the most common malignant brain tumor but treatment options are limited. Thus, there is an unmet clinical need for compounds and corresponding targets that could inhibit GBM growth. We screened a library of 80 dopaminergic ligands with the aim of identifying compounds capable of inhibiting GBM cell line proliferation and survival. Out of 45 active compounds, 8 were further validated. We found that the dopamine receptor D2 antagonist Trifluoperazine (cas 117-89-5) 2HCl inhibits growth and proliferation of GBM cells in a dose dependent manner. Trifluoperazine's inhibition of GBM cells is cell line dependent and correlates with variations in dopamine receptor expression profile. We conclude that components of the dopamine receptor signaling pathways are potential targets for pharmacological interventions of GBM growth.
We also recommend Trading Suppliers and Manufacturers of Trifluoperazine (cas 117-89-5). Pls Click Website Link as below: cas 117-89-5 suppliers
Prev:Reprint of: A chemical screen identifies Trifluoperazine (cas 117-89-5) as an inhibitor of glioblastoma growth
Next:The antipsychotic Trifluoperazine (cas 117-89-5) reduces marble-burying behavior in mice via D2 and 5-HT2A receptors: Implications for obsessive–compulsive disorder) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The calmodulin inhibitor and antipsychotic drug Trifluoperazine (cas 117-89-5) inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells09/03/2019
- ORIGINAL ARTICLESeparation and determination of Trifluoperazine (cas 117-89-5) and prochlorperazine in pharmaceutical preparations by HPLC09/02/2019
- Original articleMean centering of ratio spectra and successive derivative ratio spectrophotometric methods for determination of isopropamide iodide, Trifluoperazine (cas 117-89-5) hydrochloride and Trifluoperazine (cas 117-89-5) oxidative degradate09/01/2019
- Trifluoperazine (cas 117-89-5) blocks the human cardiac sodium channel, Nav1.5, independent of calmodulin08/31/2019
- Block of Kv4.3 potassium channel by Trifluoperazine (cas 117-89-5) independent of CaMKII08/30/2019
- The antipsychotic Trifluoperazine (cas 117-89-5) reduces marble-burying behavior in mice via D2 and 5-HT2A receptors: Implications for obsessive–compulsive disorder08/29/2019
- Reprint of: A chemical screen identifies Trifluoperazine (cas 117-89-5) as an inhibitor of glioblastoma growth08/27/2019
- Research paperRepositioning of the antipsychotic Trifluoperazine (cas 117-89-5): Synthesis, biological evaluation and in silico study of Trifluoperazine (cas 117-89-5) analogs as anti-glioblastoma agents08/26/2019
-
Health and Chemical more >